<DOC>
	<DOCNO>NCT00442377</DOCNO>
	<brief_summary>The objective study induce protective immune response malaria healthy human volunteer . The different part immune response study .</brief_summary>
	<brief_title>Study Investigate Induction Protective Immune Response Malaria</brief_title>
	<detailed_description>Efforts develop vaccine malaria still represent substantial focus current research activity . Factors hamper development subunit vaccine include complexity malaria life cycle , wide variety immune response induce malaria parasite , incomplete knowledge protective immunity . This study therefore aim induce protective immunity malaria 15 healthy volunteer . Volunteers expose bite infectious mosquito 3 time live P. falciparum sporozoites chloroquine prophylaxis . Challenge infect mosquito give stop chloroquine prophylaxis . Five volunteer form control group ; expose non-infectious mosquito chloroquine prophylaxis . Endpoints include time height parasitemia challenge , development fever immunological parameter .</detailed_description>
	<mesh_term>Malaria</mesh_term>
	<mesh_term>Malaria , Falciparum</mesh_term>
	<criteria>Age &gt; 18 &lt; 45 year healthy volunteer ( male female ) . General good health base history clinical examination . All volunteer sign informed consent form . Negative pregnancy test . Use adequate contraception female Reachable phone whole study period . Volunteer agree inform general practitioner agree sign request medical information concern contraindication participation trial History malaria residence malaria endemic area within past six month . Positive serology P. falciparum Previously participate malaria vaccine study Symptoms , physical sign laboratory value suggestive systemic disorder , include renal , hepatic , cardiovascular , pulmonary , skin , immunodeficiency , psychiatric condition , could interfere interpretation study result compromise health volunteer . Cardiovascular risk &gt; 10 % accord European guideline , take account sex , age , cholesterol , weight , smoke habit , blood pressure , diabetes Any laboratory abnormality screen blood sample beyond normal range , define UMC St Radboud . Positive HIV , HBV HCV test . Volunteers enrol clinical trial whole trial period . Volunteers receive chronic medication , especially immunosuppressive agent ( steroid , immunomodulating immunosuppressive drug ) three month precede screen visit study period . Pregnant lactating woman . Volunteers unable give write informed consent . Volunteers unable closely follow social , geographic psychological reason . Previous history drug alcohol abuse interfere normal social function period one year prior enrolment study . Known hypersensitivity antimalaria drug Volunteers allow travel malaria endemic country study period .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Falciparum</keyword>
	<keyword>Plasmodium</keyword>
	<keyword>Malaria</keyword>
</DOC>